NK Cell Proliferation Induced by IL-15 Transpresentation Is Negatively Regulated by Inhibitory Receptors
- Anton, Olga M. 2
- Vielkind, Susina 2
- Peterson, Mary E. 2
- Tagaya, Yutaka 1
- Long, Eric O. 2
- 1 †Division of Basic Science and Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201
- 2 *Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852; and
ISSN: 0022-1767, 1550-6606
Año de publicación: 2015
Volumen: 195
Número: 10
Páginas: 4810-4821
Tipo: Artículo
Otras publicaciones en: The Journal of Immunology
Resumen
IL-15 bound to the IL-15Rα–chain (IL-15Rα) is presented in trans to cells bearing the IL-2Rβ–chain and common γ-chain. As IL-15 transpresentation occurs in the context of cell-to-cell contacts, it has the potential for regulation by and of other receptor–ligand interactions. In this study, human NK cells were tested for the sensitivity of IL-15 transpresentation to inhibitory receptors. Human cells expressing HLA class I ligands for inhibitory receptors KIR2DL1, KIR2DL2/3, or CD94-NKG2A were transfected with IL-15Rα. Proliferation of primary NK cells in response to transpresented IL-15 was reduced by engagement of either KIR2DL1 or KIR2DL2/3 by cognate HLA-C ligands. Inhibitory KIR–HLA-C interactions did not reduce the proliferation induced by soluble IL-15. Therefore, transpresentation of IL-15 is subject to downregulation by MHC class I–specific inhibitory receptors. Similarly, proliferation of the NKG2A+ cell line NKL induced by IL-15 transpresentation was inhibited by HLA-E. Coengagement of inhibitory receptors, either KIR2DL1 or CD94-NKG2A, did not inhibit phosphorylation of Stat5 but inhibited selectively phosphorylation of Akt and S6 ribosomal protein. IL-15Rα was not excluded from, but was evenly distributed across, inhibitory synapses. These findings demonstrate a novel mechanism to attenuate IL-15–dependent NK cell proliferation and suggest that inhibitory NK cell receptors contribute to NK cell homeostasis.
Referencias bibliográficas
- Caligiuri, (2008), Blood, 112, pp. 461, 10.1182/blood-2007-09-077438
- Rochman, (2009), Nat. Rev. Immunol., 9, pp. 480, 10.1038/nri2580
- DiSanto, (1995), Proc. Natl. Acad. Sci. USA, 92, pp. 377, 10.1073/pnas.92.2.377
- Kawamura, (2003), J. Immunol., 171, pp. 5085, 10.4049/jimmunol.171.10.5085
- Kennedy, (2000), J. Exp. Med., 191, pp. 771, 10.1084/jem.191.5.771
- Lodolce, (1998), Immunity, 9, pp. 669, 10.1016/S1074-7613(00)80664-0
- Suzuki, (1997), J. Exp. Med., 185, pp. 499, 10.1084/jem.185.3.499
- Vosshenrich, (2005), J. Immunol., 174, pp. 1213, 10.4049/jimmunol.174.3.1213
- Nosaka, (1995), Science, 270, pp. 800, 10.1126/science.270.5237.800
- Park, (1995), Immunity, 3, pp. 771, 10.1016/1074-7613(95)90066-7
- Imada, (1998), J. Exp. Med., 188, pp. 2067, 10.1084/jem.188.11.2067
- Dubois, (2002), Immunity, 17, pp. 537, 10.1016/S1074-7613(02)00429-6
- Koka, (2003), J. Exp. Med., 197, pp. 977, 10.1084/jem.20021836
- Burkett, (2004), J. Exp. Med., 200, pp. 825, 10.1084/jem.20041389
- Doherty, (1996), J. Immunol., 156, pp. 735, 10.4049/jimmunol.156.2.735
- Ogasawara, (1998), Nature, 391, pp. 700, 10.1038/35636
- Ma, (2006), Annu. Rev. Immunol., 24, pp. 657, 10.1146/annurev.immunol.24.021605.090727
- Vivier, (2008), Nat. Immunol., 9, pp. 503, 10.1038/ni1582
- Hochweller, (2008), Eur. J. Immunol., 38, pp. 2776, 10.1002/eji.200838659
- Koka, (2004), J. Immunol., 173, pp. 3594, 10.4049/jimmunol.173.6.3594
- Lucas, (2007), Immunity, 26, pp. 503, 10.1016/j.immuni.2007.03.006
- Schleicher, (2007), J. Exp. Med., 204, pp. 893, 10.1084/jem.20061293
- Ferlazzo, (2002), J. Exp. Med., 195, pp. 343, 10.1084/jem.20011149
- Bryceson, (2006), Immunol. Rev., 214, pp. 73, 10.1111/j.1600-065X.2006.00457.x
- Kärre, (2008), Nat. Immunol., 9, pp. 477, 10.1038/ni0508-477
- Long, (2008), Immunol. Rev., 224, pp. 70, 10.1111/j.1600-065X.2008.00660.x
- Burshtyn, (1996), Immunity, 4, pp. 77, 10.1016/S1074-7613(00)80300-3
- Peterson, (2008), Immunity, 29, pp. 578, 10.1016/j.immuni.2008.07.014
- Liu, (2012), Immunity, 36, pp. 600, 10.1016/j.immuni.2012.03.007
- Castillo, (2012), Cytokine, 59, pp. 479, 10.1016/j.cyto.2012.06.017
- Sato, (2007), Proc. Natl. Acad. Sci. USA, 104, pp. 588, 10.1073/pnas.0610115104
- Robertson, (1996), Exp. Hematol., 24, pp. 406
- Shimizu, (1989), J. Immunol., 142, pp. 3320, 10.4049/jimmunol.142.9.3320
- Cohen, (1999), Immunity, 10, pp. 661, 10.1016/S1074-7613(00)80065-5
- Stebbins, (2003), Mol. Cell. Biol., 23, pp. 6291, 10.1128/MCB.23.17.6291-6299.2003
- Lee, (1998), Proc. Natl. Acad. Sci. USA, 95, pp. 5199, 10.1073/pnas.95.9.5199
- Burshtyn, (2000), Curr. Biol., 10, pp. 777, 10.1016/S0960-9822(00)00568-6
- Wagtmann, (1995), Immunity, 3, pp. 801, 10.1016/1074-7613(95)90069-1
- Biassoni, (1996), J. Exp. Med., 183, pp. 645, 10.1084/jem.183.2.645
- Wagtmann, (1995), Immunity, 2, pp. 439, 10.1016/1074-7613(95)90025-X
- Saleiro, (2015), Trends Immunol., 36, pp. 21, 10.1016/j.it.2014.10.006
- Tripathi, (2010), J. Immunol., 185, pp. 2116, 10.4049/jimmunol.1000842
- Hand, (2010), Proc. Natl. Acad. Sci. USA, 107, pp. 16601, 10.1073/pnas.1003457107
- Brilot, (2007), J. Clin. Invest., 117, pp. 3316, 10.1172/JCI31751
- Long, (2013), Annu. Rev. Immunol., 31, pp. 227, 10.1146/annurev-immunol-020711-075005
- Barreira da Silva, (2011), Blood, 118, pp. 6487, 10.1182/blood-2011-07-366328
- Liu, (2010), PLoS One, 5, pp. e12870, 10.1371/journal.pone.0012870
- Schleinitz, (2008), PLoS One, 3, pp. e3278, 10.1371/journal.pone.0003278
- Imada, (2000), Mol. Immunol., 37, pp. 1, 10.1016/S0161-5890(00)00018-3
- Ruvinsky, (2006), Trends Biochem. Sci., 31, pp. 342, 10.1016/j.tibs.2006.04.003
- Marçais, (2014), Nat. Immunol., 15, pp. 749, 10.1038/ni.2936
- Klingmüller, (1995), Cell, 80, pp. 729, 10.1016/0092-8674(95)90351-8
- Elpek, (2010), Proc. Natl. Acad. Sci. USA, 107, pp. 21647, 10.1073/pnas.1012128107